Follow The Filings

XFOR X4 Pharmaceuticals

X4 Pharmaceuticals earnings company data as of 6:59 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by XFOR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All XFOR insider trades
  • $262K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Adam R Craig Chair
    Buy
    $12K 4,600 shares at $2.58 +1.4% to stake
    Traded Oct 16 Filed Oct 19
    ↗
  2. Adam R Craig Chair
    Buy
    $250K 86,206 shares at $2.90 +30% to stake
    Traded Oct 23, 2025 Filed Oct 27, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 5 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 1.01,1.02,2.03,3.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K/A 5.02,5.07,9.01 Filing Doc
8-K 5.02,5.07 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.